Skip to main content
. Author manuscript; available in PMC: 2016 Jun 24.
Published in final edited form as: Curr Treat Options Neurol. 2014 Nov;16(11):319. doi: 10.1007/s11940-014-0319-0
Standard dosage 20 mg/day dose used in study
Contraindication agitated state, advanced arteriorsclerosis, symptomatic cardiovascular disease,
history of drug dependency, glaucoma, moderate to severe hypertension,
hyperthyroidism
Main drug interactions concomitant use with MAOI may result in hypertensive crisis
Main side effects tachycardia, myocardial infarction, Raynaud’s, peripheral vascular disease, ce-
rebrovascular accident, intracranial hemorrhage, lowered seizure threshold,
aggressive behavior, psychotic disorder, drug dependence
Special points schedule II medication, high potential for abuse
Cost expensive compared to other oral agents
Standard dosage 40 mg dose used in study
Contraindication glaucoma, marked agitation, motor tics, Tourette’s syndrome, severe anxiety,
severe cardiovascular disease, hyperthyroidism
Main drug interactions concomitant use of MAOIs, anorexiants
Main side effects decrease in appetite, insomnia, peripheral vascular disease, Raynaud’s, lowered
seizure threshold, priapism, mania, drug dependence
Special points schedule II medication, high risk for abuse
Cost expensive compared to other oral agents